| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Product Strategy Officer | Sr. VP, New Prod. Strat. &Dev | Sr. VP, New Product Dev.
1 company
Kieffer Tara Lynn is a Chief Product Strategy Officer at ENANTA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $470K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ENTA Enanta Pharmaceuticals Inc | Chief Product Strategy Officer | Sell | 2,106 | $14.23 | $29,968.38 | -6.4% | -5.8% | - | |
| Dec 6, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Product Strategy Officer | Sell | 2,283 | $8.06 | $18,400.98 | -7.2% | -10.3% | +82.5% | |
| Jun 17, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Product Strategy Officer | Sell | 7,266 | $12.33 | $89,589.78 | -18.3% | -2.2% | -41.6% | |
| Dec 5, 2023 | ENTA Enanta Pharmaceuticals Inc | Sr. VP, New Prod. Strat. &Dev | Sell | 2,125 | $9.63 | $20,463.75 | -5.4% | +65.3% | -9.9% |